Issuu on Google+

GLUCOSAMINE MARKET SIZE Scope of the Study Glucosamine report covers the types of Glucosamine and the various Applications of Glucosamine. The types of Glucosamine covered include D-Glucosamine and N-Acetyl-Glucosamine. The Applications of Glucosamine include Nutraceuticals/Pharmaceuticals, Feed Additives, Food Ingredients and Other (such as Cosmetology and Research and Development). The report provides a market analysis of each of the types and applications by their respective categories. The study includes estimates and projections for the total global Glucosamine market and also key regional markets that include North America, Europe, China, AsiaPacific (excluding China) and Rest of World. Estimates and projections are illustrated graphically. Business profiles of 49 major companies engaged in glucosamine production and glucosamine derived products are discussed in the report. The report serves as a guide to global Glucosamine industry, covering more than 245 companies that are engaged in the production, development, and supply of Glucosamine. Major glucosamine derived products are also discussed in the report. Companies producing glucosamine derived nutritional supplements, feed additives, food ingredients, and other related products are also mentioned. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Glucosamine report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in –       

Gauging Competitive Intelligence Identifying Key Growth Areas and Opportunities Understanding Geographic Relevance to Product Knowing Regional Market Sizes and Growth Opportunities and Restraints Keeping Tab on Emerging Technologies Equity Analysis Tapping New Markets

Analytics and data presented in this report pertain to several parameters such as –       

Global and Regional Market Sizes, Market Shares, Market Trends Product (Global and Regional) Market Sizes, Market Shares, Market Trends Technology Trends Corporate Intelligence Key Companies By Sales, Brands, Products Consumer Behavioral Patterns Other Strategic Business Affecting Data

Research Methodology RI Technologies publishes business intelligence reports by going through a cycle of diligent research and analysis activity. Research is done using both online and offline resources. The study outline of this report is sketched on the following lines – global market analysis, regional market analysis, product segmentation, global and regional market analysis by product segment, market trends, M&A, R&D, competitive landscape,

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 1


technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future.

This report is uniquely researched and the methodology includes: 

Need and Scope of Study

Product Definitions

Segmental Analysis

Regional Analysis

Exclusive Data Analytics

Corporate Intelligence

Feedback

Right from concept to final compilation of this report, both primary and secondary research methods are applied. We have provided exclusive feedback forms/pre-release questionnaires for this report to use the information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Our compilation of easy to navigate PDF reports are essential value addition resources for leading and growing companies.

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 2


II. REPORT SYNOPSIS Joint Supplements A Supplement in common terms is defined as any substance providing elements to support or build the body, develop the potentials of the body or any task of the body, synthesize essential elements of the body, or to provide the elements which the body is unable to synthesize or failing produce in amounts necessary. These supplements are named depending on the site of their functioning for example joint supplements provide energy in the junctions of the bones. Joint supplements are used as they are advantageous in 

Reconstruction of the damaged or worn out joint tissues and fluids,

Elimination of irritations and pain causing poisons from the body and

As an analgesic which decreases the pain in the joints of the patients.

The joint supplement is designed or developed keeping in view that it not only helps the reconstruction of the joints but also relieves the patient from pain and removes the toxins causing allergies and other detrimental effects. The supplements should not only provide relief to the patients but also should be helpful in repairing the damaged tissue and in the process should not harm the patient. Supplements now are taking a significant place in the diet of the humans and animals due to the numerous and changed life styles adapted in the present living systems. The choice of the supplement should be done depending on the 

Requirement of the body

Ingredients of the supplement

Properties of the ingredients present in the supplement

Production conditions of the supplements and

Company synthesizing the supplements.

The choice could be simple if one chooses the supplements to relieve pain and which cause no effects during the course of their use. Steroids, NSAIDs or other medications give a temporary relief to the patient but on continuous use cause adverse effects on the other organs of the body. So, the use of steroids, NSAIDs or other medications as supplements should be avoided. In some cases, the use of the stronger NSAIDs or prescription arthritis medications becomes necessary and unavoidable. In such situations, the combined use of the stronger NSAIDs or prescription arthritis medications along with the joint supplements would reduce the risk of damage of other organs and accumulation of toxins in the body. The performance of the drug to cure the patient would also increase. Not always the mixing of the drug and the joint supplement provide the cure to the patient but the combination may sometimes result in chemical reactions between them causing harm to the patient.

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 3


Glucosamine Glucosamine is a material that naturally occurs in the joints of the body. It is synthesized by the body from glucose (sugar) and glutamine. Glucosamine helps in making and repairing cartilage in the body. As humans grow old, the ability of the body to produce Glucosamine from glucose and glutamine also declines due to a decrease in the enzyme that aids production of Glucosamine. When Glucosamine Sulfate is not available in sufficient quantities, there is a degeneration of the cartilage. Glucosamine supplements could restore the Glucosamine levels in the body and also repair joints that are destroyed by osteoarthritis or other wounds. Glucosamine is present in five different forms: 

D-Glucosamine Hydrochloride (HCl)

D-Glucosamine Sulphate (2 molecules of KCl)

D-Glucosamine Sulphate NaCl

N-Acetyl-Glucosamine (NAG)

Poly N-Acetyl-Glucosamine (Poly NAG)

The IUPAC name for Glucosamine is “D-Glucosamine”. This name is not valid for N-Acetyl-Glucosamine (NAG) and Poly N-Acetyl-Glucosamine (Poly NAG).

Segmentation of Glucosamine Exhibit 1. Segmentation of Global Glucosamine Market by Type and by Application Type

Application

D-Glucosamine

Nutraceuticals/Pharmaceuticals

N-Acetyl-Glucosamine

Feed Additives Food Ingredients *Other

*Other includes Cosmetology, Research and Development © RIT, 2013

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 4


Global Market Analysis Global Market for Glucosamine is estimated at US$ XX.XX billion in 2012 and is projected to reach US$ XX.XX billion by 2020 growing at a CAGR of XX.XX % during the analysis period (2000-2020). Exhibit 2. Glucosamine – Global Value Market Historic Analysis (2000-2005) in US$ Million Year

Value

2000

XX.XX

2001

XX.XX

2002

XX.XX

2003

XX.XX

2004

XX.XX

2005

XX.XX

CAGR%

XX.XX

© RIT Figures, 2013

US$ Million

2000

2001

2002

2003

2004

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

2005

Sample Page - 5


Exhibit 3. Glucosamine – Global Value Market Estimations & Predictions (2005-2020) in US$ Billion Year

Value

2005

XX.XX

2006

XX.XX

2007

XX.XX

2008

XX.XX

2009

XX.XX

2010

XX.XX

2011

XX.XX

2012

XX.XX

2013

XX.XX

2014

XX.XX

2015

XX.XX

2016

XX.XX

2017

XX.XX

2018

XX.XX

2019

XX.XX

2020

XX.XX

CAGR%

XX.XX

© RIT Figures, 2013

US$ Billion

2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 6


III. MARKET DYNAMICS Market Overview Glucosamine based products were classified as nutraceuticals in most countries worldwide. But now a number of countries (especially Europe) are permitting glucosamine products to be registered as pharmaceuticals. Products sold as drugs need to be approved by national medicines agencies, whereas nutraceuticals in general are governed by much less demanding food regulations. As a result of the US anti-dumping action against shrimp shells from India and the EU ban on seafood imports from China, there was a steep rise in the price of Glucosamine. But since the uplift of the ban price of glucosamine has more or less stabilized. Change in the status of Glucosamine from drug to food has led to the market being opened up. Since its entrance on the food market, glucosamine has tripled in sales The recommended dose of glucosamine is 1,500mg. Putting that level into food may cause an issue, due to its taste and also the expense. Coca-Cola branched out into glucosamine in the US with fortified juice Minute Maid Active, while Smooth Walking, an energy drink aimed at people over 40 who want to keep agile, was launched in Japan. However, glucosamine fortified drinks haven't seen much success in Europe. In 2005 Complan Active, a glucosamine fortified juice for seniors, was discontinued. Delamere Dairy's Top Life Prime Time goat's milk fortified with glucosamine and chondroitin met a similar fate in 2007, after just a year on the market. Growth of the Glucosamine market is bound to continue, mainly driven by the following three factors: 

More number of countries are permitting the registration of glucosamine based drugs

Increasing usage of glucosamine in the treatment of Osteoarthritis

There is a constant increase in occurrence of Osteoarthritis mainly due to the ageing population

Glucosamine supplements have witnessed healthy sales worldwide. But with a constant stream of new products saturating the market, manufacturers are starting to consider new applications for the amino sugar and have found the food industry the most promising. The introduction of combination products such as Vitabiotics' Jointace [supplement] with collagen, glucosamine and chondroitin are undercutting sales for single glucosamine dietary supplements on the market.

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 7


Global Market Analysis Global Glucosamine market in terms of volume was reported at about XX.XX thousand metric tons in 2012. The market during 2000 -2020 grew at a CAGR of XX.XX % to reach XX.XX thousand metric tons in 2020. Exhibit 4. Glucosamine – Global Volume Market Analysis (2000-2005) by Geographic Region for North America, Europe, China, Asia-Pacific and Rest of World in Metric Tons Year/Region

North America

Europe

China

Asia-Pacific

Rest of World

Total

2000

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2001

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2002

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2003

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2004

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2005

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

CAGR%

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

© RIT Figures, 2013

US$ Million

2000 North America

2001

2002 Europe

2003 China

2004 Asia-Pacific

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

2005 Rest of World

Sample Page - 8


Exhibit 5. Glucosamine – Global Volume Market Analysis (2005-2020) by Geographic Region for North America, Europe, China, Asia-Pacific and Rest of World in Metric Tons Year/Region

North America

Europe

China

Asia-Pacific

Rest of World

Total

2005

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2006

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2007

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2008

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2009

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2010

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2011

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2012

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2013

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2014

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2015

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2016

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2017

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2018

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2019

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2020

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

CAGR%

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

© RIT Figures, 2013

US$ Million

2005

2006

2007

2008

North America

2009

2010 Europe

2011

2012

2013

China

2014

2015

2016

2017

Asia-Pacific

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

2018

2019

2020

Rest of World

Sample Page - 9


Exhibit 6. Glucosamine – Global Volume Market Shares (2000, 2015 &2020) by Geographic Region for North America, Europe, China, Asia-Pacific and Rest of World in Metric Tons Year/Region

North America

Europe

China

Asia-Pacific

Rest of World

Total

2000

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2015

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

2020

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

CAGR%

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

XX.XX

© RIT Figures, 2013

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 10


Analysis by Type D-Glucosamine market is the largest type globally and is estimated at US$XX.XX billion in 2012 with a market share of XX.XX % (2012) and is forecast to reach US$ XX.XX billion by 2020 with a CAGR of XX.XX %. N-Acetyl is the faster growing with a CAGR of XX.XX % during the analysis period. Exhibit 7. Glucosamine -Global Value Market Estimations & Predictions (2000-2005) by Type for DGlucosamine and N-Acetyl-Glucosamine in US$ Million Year/Type

D-Glucosamine

N-Acetyl Glucosamine

Total

2000

XX.XX

XX.XX

XX.XX

2001

XX.XX

XX.XX

XX.XX

2002

XX.XX

XX.XX

XX.XX

2003

XX.XX

XX.XX

XX.XX

2004

XX.XX

XX.XX

XX.XX

2005

XX.XX

XX.XX

XX.XX

CAGR%

XX.XX

XX.XX

XX.XX

© RIT Figures, 2013

US$ Million

2000

2001 D-Glucosamine

2002

2003

2004

2005

N-Acetyl Glucosamine

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 11


Exhibit 8. Glucosamine -Global Value Market Estimations & Predictions (2005-2020) by Type for DGlucosamine and N-Acetyl-Glucosamine in US$ Million Year/Type

D-Glucosamine

N-Acetyl Glucosamine

Total

2005

XX.XX

XX.XX

XX.XX

2006

XX.XX

XX.XX

XX.XX

2007

XX.XX

XX.XX

XX.XX

2008

XX.XX

XX.XX

XX.XX

2009

XX.XX

XX.XX

XX.XX

2010

XX.XX

XX.XX

XX.XX

2011

XX.XX

XX.XX

XX.XX

2012

XX.XX

XX.XX

XX.XX

2013

XX.XX

XX.XX

XX.XX

2014

XX.XX

XX.XX

XX.XX

2015

XX.XX

XX.XX

XX.XX

2016

XX.XX

XX.XX

XX.XX

2017

XX.XX

XX.XX

XX.XX

2018

XX.XX

XX.XX

XX.XX

2019

XX.XX

XX.XX

XX.XX

2020

XX.XX

XX.XX

XX.XX

CAGR%

XX.XX

XX.XX

XX.XX

© RIT Figures, 2013

US$ Million

2005

2006

2007

2008

2009

2010

D-Glucosamine

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

N-Acetyl Glucosamine

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 12


Exhibit 9. Glucosamine -Global Value Market Shares (2000, 2015 &2020) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million Year/Type

D-Glucosamine

N-Acetyl Glucosamine

Total

2000

XX.XX

XX.XX

XX.XX

2015

XX.XX

XX.XX

XX.XX

2020

XX.XX

XX.XX

XX.XX

CAGR%

XX.XX

XX.XX

XX.XX

© RIT Figures, 2013

IV. PRODUCT TECHNOLOGY/RESEARCH Exhibit 10. List of Available Glucosamine based Drugs Trade Name

Company

Composition

Indication

AB AUSBIOBONE

Max Biocare Pty. Ltd. (Australia)

Glucosamine Sulfate, Chondroitin Sulfate-shark & Manganese

Arthritis, Osteoarthritis, Rheumatism, Gout & Back Pain

AB Carsa Giox

Max Biocare Pty. Ltd. (Australia)

Ginger, Glucosamine & Chondroitin Sulfate

Low Back pain, Osteoarthritic Pain, Rheumatism & Osteoarthritis

AB GLUCOSAMINE

Max Biocare Pty. Ltd. (Australia)

Glucosamine Sulfate Potassium Chloride Complex

Arthritis, Gout & Rheumatism

AB ORIOSTIN

Max Biocare Pty. Ltd. (Australia)

Glucosamine Sulfate, Ginger & Manganese

Arthritis, Osteoarthritis, Rheumatism, Gout & Back Pain

More…… © RIT, 2013

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 13


GLUCOSAMINE - THE OUTLOOK Glucosamine is the most sought after product in terms of joint health. It may not be a complete cure for Osteoarthritis, but with mounting scientific proof and some of the world's leading manufacturers behind it, there could be a good profit in the glucosamine functional food market. The application of Glucosamine in other fields such as body building, wound healing, inflammatory bowel disorders, cosmetology, etc. has considerably increased the need and production of Glucosamine. Consumer demand for dietary supplements is growing stronger more than before, thereby crossing demographic lines and expanding market opportunities for brand owners across a wide range of products. Consumers look towards low-cost, anti-medical, general well being products more than drugs. Moreover, supplement manufacturers are now required to follow Current Good Manufacturing Practices (CGMP), the federal regulations that are typically associated with the manufacture of drug products. This is considered as a major shift for glucosamine manufacturers. Also, manufacturers should conduct full testing on all active ingredients in multi-active products, as per a new regulation. Contract manufacturers and brand owners of glucosamine products need to collaborate closely to develop and manufacture highquality products that meet consumer demand while maximizing profits. Researchers are still having debates on the success of glucosamine and chondroitin remedies for osteoarthritis. Glucosamine is largely utilized in the formation and repair of the cartilage while chondroitin is responsible for the durability and sturdiness of the cartilage. Global Market for Glucosamine is estimated at US$XX.XX billion in 2012 and is projected to reach US$ XX.XX billion by 2020 growing at a CAGR of XX.XX % during the analysis period (2005-2020). Global volume market for Glucosamine was reported at US$ XX.XX thousand metric tons in 2000. The market reached XX.XX thousand metric tons in 2005 growing at a CAGR of XX.XX %. Glucosamine application in Nutraceuticals/Pharmaceuticals is the leading market segment globally valued at about US$ XX.XX billion in 2010 and is forecast to reach US$ XX.XX billion by 2020 with a market share of XX.XX % (2020). Food Ingredients is the fastest growing application of Glucosamine with a CAGR of XX.XX % closely followed by Other applications (XX.XX %) and Feed Additives (XX.XX %) during the analysis period 2005-2020. Globally, glucosamine products have seen about 50% increase in launches in the past five years. The leading markets include Asia Pacific, Europe and North America. In the future, many functional food products would come out in less developed regions of the Latin America and Asia Pacific…….

About RI Technologies RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development.

Research – As Good as the Methodology is!

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 14


Gauging Competitive Intelligence

Identifying Key Growth Areas and Opportunities

Understanding Geographic Relevance to Product

Knowing Regional Market Sizes and Growth Opportunities and Restraints

Keeping Tab on Emerging Technologies

Equity Analysis

Tapping New Markets

© COPYRIGHT The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company.

DISCLAIMER RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data.

RITMIR017: Glucosamine – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com

Sample Page - 15


Glucosamine Market report